Lensar (LNSR) Liabilities and Shareholders Equity (2019 - 2026)

Lensar (LNSR) reported Liabilities and Shareholders Equity of $66.2 million for Q1 2026, down 9.23% year-over-year from $73.0 million in Q1 2025, and down 7.29% quarter-over-quarter from $71.4 million in Q4 2025.

Lensar (LNSR) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $66.2 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $66.2 million, down 9.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $278.3 million (up 5.93% YoY), and the FY2025 annual result was $71.4 million, up 7.74% from the prior year.
  • Liabilities and Shareholders Equity retreated to $66.2 million in Q1 2026 per LNSR's latest filing, from $71.4 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $73.0 million in Q1 2025 and troughed at $52.0 million in Q1 2023.
  • A 5-year average of $64.7 million and a median of $66.2 million in 2026 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity slipped 19.53% in 2022, then rose 29.29% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $55.8 million in 2022, then gained by 24.61% to $69.6 million in 2023, then retreated by 4.73% to $66.3 million in 2024, then advanced by 7.74% to $71.4 million in 2025, then fell by 7.29% to $66.2 million in 2026.
  • Business Quant data shows LNSR's Liabilities and Shareholders Equity at $66.2 million in Q1 2026, $71.4 million in Q4 2025, and $70.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 46.29 Bn
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn 6.63 Bn
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn 37.13 Bn
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn 10.74 Bn
10 Lensar 68.71 Mn 69.00 Mn 6.38 Mn 66.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66.22 Mn
Dec 31, 2025 71.43 Mn
Sep 30, 2025 70.20 Mn
Jun 30, 2025 70.41 Mn
Mar 31, 2025 72.96 Mn
Dec 31, 2024 66.30 Mn
Sep 30, 2024 62.02 Mn
Jun 30, 2024 61.41 Mn
Mar 31, 2024 66.13 Mn
Dec 31, 2023 69.59 Mn
Sep 30, 2023 70.85 Mn
Jun 30, 2023 71.20 Mn
Mar 31, 2023 51.96 Mn
Dec 31, 2022 55.84 Mn
Sep 30, 2022 54.80 Mn
Jun 30, 2022 58.70 Mn
Mar 31, 2022 60.30 Mn
Dec 31, 2021 66.47 Mn
Sep 30, 2021 68.10 Mn
Jun 30, 2021 72.48 Mn